FDA.reportPublic FDA data

NADOLOL

Substance profile for UNII FEN504330V, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
FEN504330V
Preferred term
NADOLOL
Registry number
42200-33-9
EC number
255-706-3
Ingredient type
INGREDIENT SUBSTANCE

Chemical And Database Identifiers#

RxCUI
7226
PubChem
0
NCIt
C29280
INN ID
3875

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm7226https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=7226
NCI ThesaurusC29280https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C29280
FDA Substance Registration SystemFEN504330Vhttps://precision.fda.gov/uniisearch/srs/unii/FEN504330V
European Community number255-706-3https://commonchemistry.cas.org/results?q=255-706-3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
NADOLOLACTIVE INGREDIENTFEN504330Vd208918b-a356-4924-91d9-9593981fe0a64
NADOLOLACTIVE MOIETYFEN504330Vd208918b-a356-4924-91d9-9593981fe0a64
NadololACTIVE INGREDIENTFEN504330VNADOLOL TABLETS USP Rx only1
NadololACTIVE MOIETYFEN504330VNADOLOL TABLETS USP Rx only1
NADOLOLACTIVE INGREDIENTFEN504330VNadolol Tablets, USP1
NADOLOLACTIVE MOIETYFEN504330VNadolol Tablets, USP1
NadololACTIVE INGREDIENTFEN504330VNADOLOL TABLETS USP Rx only1
NadololACTIVE MOIETYFEN504330VNADOLOL TABLETS USP Rx only1
NADOLOLACTIVE MOIETYFEN504330VNadolol Tablets, USP1
NADOLOLACTIVE INGREDIENTFEN504330VNadolol Tablets, USP1
NADOLOLACTIVE MOIETYFEN504330VNADOLOL TABLET [SANDOZ INC]13
NADOLOLACTIVE INGREDIENTFEN504330VNADOLOL TABLET [SANDOZ INC]13
NADOLOLACTIVE INGREDIENTFEN504330VCORGARD (NADOLOL) TABLET [PFIZER LABORATORIES DIV PFIZER INC]8
NADOLOLACTIVE MOIETYFEN504330VCORGARD (NADOLOL) TABLET [PFIZER LABORATORIES DIV PFIZER INC]8
NADOLOLACTIVE MOIETYFEN504330VCORZIDE (NADOLOL AND BENDROFLUMETHIAZIDE) TABLET [PFIZER LABORATORIES DIV PFIZER INC]8
NADOLOLACTIVE INGREDIENTFEN504330VCORZIDE (NADOLOL AND BENDROFLUMETHIAZIDE) TABLET [PFIZER LABORATORIES DIV PFIZER INC]8
NADOLOLACTIVE INGREDIENTFEN504330VNADOLOL TABLET [TEVA PHARMACEUTICALS USA INC]7
NADOLOLACTIVE MOIETYFEN504330VNADOLOL TABLET [TEVA PHARMACEUTICALS USA INC]7
NADOLOLACTIVE INGREDIENTFEN504330VNADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]4
NADOLOLACTIVE MOIETYFEN504330VNADOLOL AND BENDROFLUMETHIAZIDE TABLET [GLOBAL PHARMACEUTICALS, DIVISION OF IMPAX LABORATORIES, INC.]4
NADOLOLACTIVE MOIETYFEN504330VNADOLOL TABLET [MYLAN PHARMACEUTICALS INC.]4
NADOLOLACTIVE INGREDIENTFEN504330VNADOLOL TABLET [MYLAN PHARMACEUTICALS INC.]4
NADOLOLACTIVE MOIETYFEN504330VNADOLOL TABLET [AMERICAN HEALTH PACKAGING]3
NADOLOLACTIVE INGREDIENTFEN504330VNADOLOL TABLET [AMERICAN HEALTH PACKAGING]3
NADOLOLACTIVE MOIETYFEN504330VNADOLOL TABLET [BLUEPOINT LABORATORIES]2
NADOLOLACTIVE INGREDIENTFEN504330VNADOLOL TABLET [BLUEPOINT LABORATORIES]2
NADOLOLACTIVE MOIETYFEN504330VNADOLOL TABLET [GREENSTONE LLC]2
NADOLOLACTIVE INGREDIENTFEN504330VNADOLOL TABLET [GREENSTONE LLC]2
NADOLOLACTIVE INGREDIENTFEN504330VNADOLOL TABLET [MYLAN INSTITUTIONAL INC.]2
NADOLOLACTIVE MOIETYFEN504330VNADOLOL TABLET [MYLAN INSTITUTIONAL INC.]2
NADOLOLACTIVE INGREDIENTFEN504330VNADOLOL TABLET [REMEDYREPACK INC. ]2
NADOLOLACTIVE MOIETYFEN504330VNADOLOL TABLET [REMEDYREPACK INC. ]2
NADOLOLACTIVE MOIETYFEN504330VNADOLOL TABLET [AMERICAN HEALTH PACKAGING]1
NADOLOLACTIVE INGREDIENTFEN504330VNADOLOL TABLET [AMERICAN HEALTH PACKAGING]1
NADOLOLACTIVE MOIETYFEN504330VNADOLOL TABLET [AMERICAN HEALTH PACKAGING]1
NADOLOLACTIVE INGREDIENTFEN504330VNADOLOL TABLET [AMERICAN HEALTH PACKAGING]1